Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2022 | 1 |
2023 | 2 |
2024 | 0 |
Search Results
3 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Co-targeting HSP90 alpha and CDK7 overcomes resistance against HSP90 inhibitors in BCR-ABL1+ leukemia cells.
Cell Death Dis. 2023 Dec 6;14(12):799. doi: 10.1038/s41419-023-06337-3.
Cell Death Dis. 2023.
PMID: 38057328
Free PMC article.
Development of the first geldanamycin-based HSP90 degraders.
Wurnig S, Vogt M, Hogenkamp J, Dienstbier N, Borkhardt A, Bhatia S, Hansen FK.
Wurnig S, et al. Among authors: hogenkamp j.
Front Chem. 2023 Jun 28;11:1219883. doi: 10.3389/fchem.2023.1219883. eCollection 2023.
Front Chem. 2023.
PMID: 37448856
Free PMC article.
Item in Clipboard
Synthesis, Antiplasmodial, and Antileukemia Activity of Dihydroartemisinin-HDAC Inhibitor Hybrids as Multitarget Drugs.
von Bredow L, Schäfer TM, Hogenkamp J, Tretbar M, Stopper D, Kraft FB, Schliehe-Diecks J, Schöler A, Borkhardt A, Bhatia S, Held J, Hansen FK.
von Bredow L, et al. Among authors: hogenkamp j.
Pharmaceuticals (Basel). 2022 Mar 9;15(3):333. doi: 10.3390/ph15030333.
Pharmaceuticals (Basel). 2022.
PMID: 35337131
Free PMC article.
Item in Clipboard
Cite
Cite